Get started
Author

Javier Delgado

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
2022 · Mi Kwon, Gloria Iacoboni, et al. · Haematologica · 149
PDF
Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy
2024 · Gloria Iacoboni, Josu Iraola‐Truchuelo, et al. · HemaSphere · 47
PDF
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO
2024 · Rebeca Bailén, Gloria Iacoboni, et al. · Transplantation and Cellular Therapy · 26
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment
2024 · Gloria Iacoboni, Víctor Navarro, et al. · Journal of Hematology & Oncology · 19
PDF
Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy
2022 · Gloria Iacoboni, Josu Iraola-Truchuelo, et al. · Blood · 19
Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
2025 · Mariana Bastos‐Oreiro, Gloria Iacoboni, et al. · HemaSphere · 8
PDF
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study
2023 · Mariana Bastos-Oreiro, Antonio Gutierrez, et al. · Transplantation and Cellular Therapy · 8
PDF
Female Sex Effect on Anti-CD19 CART Cell Therapy for Relapsed/Refractory B-Cell Lymphoma: A Grupo Español De Trasplante y Terapia Celular (GETH-TC) Study
2023 · Nicole Fabbri, Marta Peña, et al. · Blood · 2
The Post-CAR Prognostic Index (PC-PI): A New Prognostic Score to Predict Overall Survival in Large B-Cell Lymphoma Patients Progressing after Chimeric Antigen Receptor T-Cell Therapy
2023 · Gloria Iacoboni, Victor Navarro Garces, et al. · Blood · 2
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy
2025 · Anna Torrent, Mireia Morgades, et al. · Bone Marrow Transplantation · 1
Clinical Features and Outcomes of Therapy-Related Myeloid Neoplasms After CAR T-Cell Therapy
2026 · Michael D Jain, Alaa Ali, et al. · Blood Advances
PDF
Consolidative allogeneic HCT vs. a watch-and-wait approach for B-cell acute lymphoblastic leukemia patients with early loss of B-cell aplasia after CAR T-cell therapy
2026 · Sergi Camarillas, Anna Alonso-Saladrigues, et al. · Bone Marrow Transplantation
Impact of Patient Selection and Management over Different Time Periods on the Outcome of Patients with Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
2023 · Anna Torrent, Mireia Morgades, et al. · Blood
Impact of Scholar-1 Refractoriness Criteria on the Efficacy of CAR-T Therapy in Aggressive B Cell Lymphoma, Compared with Non-Refractory Patients: A Real World Geltamo/Geth Study
2022 · Mariana Bastos-Oreiro, Antonio Gutierrez, et al. · Blood
Works count: 14
Citation count: 281
H-index: 7
I10-index: 5
Year
Topic
Type